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Introduction
We conducted an observational study of patients attending
our outpatient headache clinic, suffering from episodic
tension-type headache (ETTH) and migraine without aura
(MO). The purpose of the study was to compare the effi-
cacy of magnesium bisglycinate, L-tryptophan, niacin, vita-
min B2 and vitamin D, pineal tens (PT) and amitriptyline
(A) in the prophylaxis [1-4] of these primary headaches
using as outcomes: pain modification with visual analogue
scale (VAS); the change in the number of attacks/month;
the change in the consumption of analgesics/month.
Patients and methods
ETTH and MO were diagnosed according to the Interna-
tional Classification ICHD-II criteria. We studied a total of
200 patients: 100 patients were diagnosed with ETTH and
100 with MO. Of these patients, 50 with a diagnosis of
ETTH (15 M, 35 F; mean age: 34 years) were treated with
PT (1 sachet morning and evening) and were compared
with 50 patients (17 M, 33 F; mean age: 39 years)
undergoing amitriptyline therapy (20 mg in the evening).
Fifty patients with MO (15 M, 35 F; mean age: 37 years)
were treated with PT (1 sachet morning and evening), and
compared with 50 patients (8 M, 42 F; mean age: 40 years)
taking A (20 mg in the evening).
Results
The VAS modifications, the number of attacks and the
number of analgesics taken during the study are shown
in Figure 1 for the patients diagnosed with ETTH. The
group treated with PT clearly showed a reduction in all
treatment outcomes during the study compared to the
group taking A.
VAS modification, the number of attacks and the
number of analgesics taken during the study are shown
in Figure 2 for the patients diagnosed with MO. The
group treated with PT clearly showed a reduction in all
treatment outcomes during the study compared to the
group taking A.
Conclusions
Our clinical observation of an improvement in headache
in patients receiving PT led us to conduct this cohort
study comparing PT with A therapy. Although this study
is obviously limited because of the absence of patient ran-
domization, its results confirm the clinical impression of
an improvement in the primary headache in patients with
PT in terms of improvement in VAS, reduction in the
number of attacks/month, and the consumption of analge-
sics/month. In fact, PT treatment was found to be more
efficacious when compared to A treatment in many out-
come measures.
Written informed consent to publish was obtained
from the patient(s).
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Figure 1 Patients with ETTH.
Figure 2 Patients with MO.
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